80
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Risk factors and clinical signs of severe Acanthamoeba keratitis

, , , , , , & show all
Pages 2567-2573 | Published online: 10 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stefano Bonini, Antonio Di Zazzo, Giuseppe Varacalli & Marco Coassin. (2021) Acanthamoeba Keratitis: Perspectives for Patients. Current Eye Research 46:6, pages 771-776.
Read now

Articles from other publishers (10)

Lidia Chomicz, Jacek P. Szaflik, Beata Szostakowska, Justyna Izdebska, Wanda Baltaza, Monika Łazicka-Gałecka, Agnieszka Kuligowska, Anna Machalińska, Paweł J. Zawadzki & Jerzy Szaflik. (2023) Successive Acanthamoeba Corneal Isolates Identified in Poland Monitored in Terms of In Vitro Dynamics. Microorganisms 11:5, pages 1174.
Crossref
Mark F F E. Padua, Frederick Ramirez Masangkay, Grecebio Jonathan D. Alejandro & Giovanni De Jesus Milanez. (2023) Detection of Acanthamoeba spp. in groundwater sources in a rural area in the Philippines . Journal of Water and Health 21:1, pages 138-146.
Crossref
Lin Chen, Liangju Kuang, Amy E. Ross, Wissam Farhat, Nikolay Boychev, Sina Sharfi, Levi N. Kanu, Longqian Liu, Daniel S. Kohane & Joseph B. Ciolino. (2022) Topical Sustained Delivery of Miltefosine Via Drug-Eluting Contact Lenses to Treat Acanthamoeba Keratitis. Pharmaceutics 14:12, pages 2750.
Crossref
Tayebeh Taghipour, Sima Rasti, Mohammadali Saba, Mahdi Delavari, Gholam Abbas Moosavi, Hossein Hooshyar & Zahra Eslamirad. (2022) Molecular detection and genotype identification of Acanthamoeba species from bronchoalveolar lavage of patients with pulmonary symptoms suspected of cancer. Journal of Parasitic Diseases 46:4, pages 1028-1035.
Crossref
Noor Akbar, Mohammed I. El-Gamal, Balsam Qubais Saeed, Chang-Hyun Oh, Mohammed S. Abdel-Maksoud, Naveed Ahmed Khan, Ahmad M. Alharbi, Hasan Alfahemi & Ruqaiyyah Siddiqui. (2022) Antiamoebic Activity of Imidazothiazole Derivatives against Opportunistic Pathogen Acanthamoeba castellanii. Antibiotics 11:9, pages 1183.
Crossref
Yesha S. Shah, Inna G. Stroh, Sidra Zafar, Nancy Zhang, Manjari Sriparna, Nakul Shekhawat, Zara Ghos, Divya Srikumaran & Fasika A. Woreta. (2021) Delayed diagnoses of Acanthamoeba keratitis at a tertiary care medical centre . Acta Ophthalmologica 99:8, pages 916-921.
Crossref
Giuseppe Varacalli, Antonio Di Zazzo, Tommaso Mori, Thomas H. Dohlman, Sara Spelta, Marco Coassin & Stefano Bonini. (2021) Challenges in Acanthamoeba Keratitis: A Review. Journal of Clinical Medicine 10:5, pages 942.
Crossref
Stine Elkjær Nielsen, Anders Ivarsen & Jesper Hjortdal. (2019) Increasing incidence of Acanthamoeba keratitis in a large tertiary ophthalmology department from year 1994 to 2018 . Acta Ophthalmologica 98:5, pages 445-448.
Crossref
Hany M. Elsheikha, Ruqaiyyah Siddiqui & Naveed Ahmed Khan. (2020) Drug Discovery against Acanthamoeba Infections: Present Knowledge and Unmet Needs. Pathogens 9:5, pages 405.
Crossref
. (2019) Betamethasone/fluorometholone. Reactions Weekly 1761:1, pages 83-83.
Crossref